Dr.Datsons Labs (Delisted) share news and announcements

BSE: 533412

Formerly Aanjaneya Lifecare

Last traded ₹6.40 on 21 May 2015

Delisted on 14 Feb 2020.

Dr.Datsons Labs share news and announcements

899 announcements, routine notices left out, newest first. Page 2 of 18.

Jan 2015
Dec 2014
- 31 Dec · Board Meeting on Jan 05, 2015
  Dr.Datsons Labs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 05, 2015, inter alia, to consider issue and allotment of equity shares ....
- 31 Dec · Board meeting
  (1) To consider issue and allotment of equity shares Pursuant to FCCBs conversion notice(s) received from the Bondholders of the company. (2) Any other matter with the permission of the Chair. (opens in a new tab)
- 22 Dec · Updates
  Dr.Datsons Labs Ltd vide its letter dated December 22, 2014 has informed BSE regarding "Message from Minister of Health & Family Welfare Government of India." (opens in a new tab)
- 22 Dec · Updates
  Dr. Datson's Labs Limited has informed the Exchange vide letter dated December 22, 2014 regarding "Message from Minister of Health & Family Welfare Government of India." (opens in a new tab)
- 16 Dec · Legal
  Exchange has sought clarification from Dr.Datsons Labs Ltd with respect to the announcement submitted by the company dated December 15, 2014 titled "Outcome of the Board Meeting" which ....
- 16 Dec · Legal
  Exchange has sought clarification from Dr.Datsons Labs Ltd with respect to disclosure dated December 15, 2014 titled "Outcome of the Board Meeting" which inter-alia stated "Taken on ....
- 15 Dec · Board meeting
  Dr.Datsons Labs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 15, 2014, has transacted the following: 1. Taken on record The Letter .... (opens in a new tab)
- 15 Dec · Board meeting
  Dr. Datson's Labs Limited has informed the Exchange regarding a Outcome of Board Meeting of the Company held on December 15, 2014. (opens in a new tab)
- 11 Dec · Disclosure
  Dr. Kannan Vishwanath has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 11 Dec · Disclosure
  Dr.Datsons Labs Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 8 Dec · Board meeting
  1.To Discussion on letter of interest received from Leaders Group Asia Limited for acquiring majority stake in the Company. 2.To Discussion on Demerger of Business of API and Formulation of the company. 3.Any other matter with the permission of the Chair.
- 8 Dec · Board Meeting on Dec 15, 2014
  Dr.Datsons Labs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on December 15, 2014, inter alia, to transact the following: 1. Discussion ....
- 2 Dec · Disclosure
  Auctor Investments Ltd has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 2 Dec · Disclosure
  Heshika Growth Fund has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 2 Dec · Disclosure
  Dr. Datson's Labs Limited has submitted to the Exchange, vide letter dated December 2, 2014, a copy of the disclosure pursuant to Regulation 13(1), 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992. (opens in a new tab)
- 2 Dec · Disclosure
  Vide letter dated December 02, 2014 a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 2 Dec · Disclosure
  Dr.Datsons Labs Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 2 Dec · Disclosure
  Dr.Datsons Labs Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 2 Dec · Disclosure
  Finaventure Capital Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 2 Dec · Disclosure
  Finaventure Capital Ltd has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 2 Dec · Disclosure
  Davos International Fund has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 2 Dec · Disclosure
  Sparrow Asia Diversified Opportunities Fund has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
Nov 2014
- 27 Nov · Disclosure
  Dr. Datson's Labs Limited has submitted to the Exchange vide letter dated November 27, 2014 a copy of disclosure pursuant to Regulation 13(1), 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992. (opens in a new tab)
- 27 Nov · Disclosure
  Dr.Datsons Labs Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 27 Nov · Dr. Datsons Labs to receive "Transformational & Come Back Company of the year" for sustained healthcare innovations
  Dr.Datsons Labs Ltd has informed BSE regarding a Press Release dated November 27, 2014, titled "Dr. Datsons Labs to receive "Transformational & Come Back Company of the year" for sustained .... (opens in a new tab)
- 27 Nov · Business
  Dr. Datson's Labs Limited has informed the Exchange regarding press release dated November 27, 2014, titled "Dr. Datson's Labs to receive "Transformational & Come Back Company of the year" for sustained healthcare Innovations". (opens in a new tab)
- 26 Nov · Disclosure
  Vide letter dated November 26, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 26 Nov · Disclosure
  Kannan Vishwanath has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 26 Nov · Disclosure
  Dr. Kannan Vishwanath has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 26 Nov · Disclosure
  Stream Value Fund has submitted the revised disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 26 Nov · Disclosure
  Vide letter dated November 26, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 26 Nov · Disclosure
  Stream Value Fund has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 18 Nov · Updates
  Dr. Datson's Labs Limited has informed the Exchange that the Company won The Coveted "Swiss International Quality Certificate". (opens in a new tab)
- 18 Nov · Swiss International Quality Certificate
  Dr.Datsons Labs Ltd has informed BSE regarding "Swiss International Quality Certificate". (opens in a new tab)
- 14 Nov · Results
  Dr.Datsons Labs Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2014. (opens in a new tab)
- 14 Nov · Results
  Dr. Datson's Labs Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Sep-2014. (opens in a new tab)
- 11 Nov · Board meeting
  Dr. Datson's Labs Limited has informed the Exchange regarding Outcome of Board Meeting held on November 11, 2014. (opens in a new tab)
- 11 Nov · Board meeting
  Dr.Datsons Labs Ltd has informed BSE regarding Outcome of Board Meeting held on November 11, 2014. (opens in a new tab)
- 10 Nov · Revised Shareholding Pattern for September 30, 2014
  With reference to earlier announcement dated October 13, 2014 regarding Shareholding Pattern for September 30, 2014, Dr.Datsons Labs Ltd has now submitted to BSE the Revised Shareholding .... (opens in a new tab)
- 7 Nov · Board meeting
  1. To consider issue and allotment of equity shares Pursuant to FCCBs conversion notice(s) received from the Bondholders of the company. 2. Any other matter with the permission of the Chair.
- 6 Nov · Board Meeting on Nov 11, 2014
  Dr.Datsons Labs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 11, 2014, inter alia, to consider issue and allotment of equity shares ....
Oct 2014
- 31 Oct · Management
  Dr.Datsons Labs Ltd has informed BSE that Mr. Giridhar Gopal Pulleti, Director of the Company, has tendered his resignation from the directorship of the Company with effect from October 27, 2014.